Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
North Atlantic Value LLP is a London-based investment management firm specializing in activist investing and smaller companies, with a significant focus on the healthcare and life sciences sectors. Founded in 2003 by Christopher Mills, the firm operates as part of the Harwood Capital Management Group and manages the North Atlantic Smaller Companies Investment Trust (NASCIT). While not a direct developer of therapeutic products, North Atlantic Value is a prominent stakeholder in the biotech ecosystem, frequently investing in healthcare providers, pharmaceutical services, and medical technology firms. The firm is known for taking strategic positions to drive operational improvements and corporate restructuring within its portfolio companies to maximize shareholder value. Notable healthcare-related involvements include positions in companies like Spire Healthcare, Medica Group, and Bioquell, making it a key entity for analysts tracking healthcare M&A and governance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North Atlantic Value.